首都医药
首都醫藥
수도의약
CAPITAL MEDICINE
2014年
4期
16-17
,共2页
药物经济学评价%重要性%质量%应用
藥物經濟學評價%重要性%質量%應用
약물경제학평개%중요성%질량%응용
Pharmacoeconomics Evaluation%Importance%Quality%Application
目的:随着社会经济的发展、人口老龄化、疾病谱的改变,特别是医疗卫生技术的变革与进步,使得全球各国医疗卫生费用的增长异常迅猛。如何利用卫生技术评估和药物经济学评价来提高医疗卫生资源的合理配置与优化使用,是世界各国共同面临的重大难题。方法本文首先提出了药物经济学评价的重要性;讨论药物经济学评价在新药研发、药品定价、医保目录选择和临床合理用药等方面的应用;探讨药物经济学评价质量的重要性;分析中国在卫生技术评估和药物经济学评价方面所面临的问题和挑战,提出了当前中国在该领域面临的四点主要问题。结果与结论提醒政府部门、医疗机构、制药企业和科研院所等共同关注这些问题并努力做好药物经济学评价工作。
目的:隨著社會經濟的髮展、人口老齡化、疾病譜的改變,特彆是醫療衛生技術的變革與進步,使得全毬各國醫療衛生費用的增長異常迅猛。如何利用衛生技術評估和藥物經濟學評價來提高醫療衛生資源的閤理配置與優化使用,是世界各國共同麵臨的重大難題。方法本文首先提齣瞭藥物經濟學評價的重要性;討論藥物經濟學評價在新藥研髮、藥品定價、醫保目錄選擇和臨床閤理用藥等方麵的應用;探討藥物經濟學評價質量的重要性;分析中國在衛生技術評估和藥物經濟學評價方麵所麵臨的問題和挑戰,提齣瞭噹前中國在該領域麵臨的四點主要問題。結果與結論提醒政府部門、醫療機構、製藥企業和科研院所等共同關註這些問題併努力做好藥物經濟學評價工作。
목적:수착사회경제적발전、인구노령화、질병보적개변,특별시의료위생기술적변혁여진보,사득전구각국의료위생비용적증장이상신맹。여하이용위생기술평고화약물경제학평개래제고의료위생자원적합리배치여우화사용,시세계각국공동면림적중대난제。방법본문수선제출료약물경제학평개적중요성;토론약물경제학평개재신약연발、약품정개、의보목록선택화림상합리용약등방면적응용;탐토약물경제학평개질량적중요성;분석중국재위생기술평고화약물경제학평개방면소면림적문제화도전,제출료당전중국재해영역면림적사점주요문제。결과여결론제성정부부문、의료궤구、제약기업화과연원소등공동관주저사문제병노력주호약물경제학평개공작。
ObjectiveWith the development of economy,and the progress of the society,the rapid growth of health care costs has become a huge burden on the world health system.This is driven by an aging population in the world,the change of disease spectrum,and particularly the progress and change of health care technology.The major problem of many countries is how to use health technology assessments (HTA) and pharmacoeconomics evaluation to improve and optimize the configuration of medical and health resources.MethodThis paper presents the importance of pharmacoeconomics evaluationand discusses the application of pharmacoeconomics evaluation in new drug research and development,drug pricing,selection of NRDL and promoting rational drug use.The quality of pharmacoeconomic evaluation is of great importance and also addressed.Furthermore,the paper analyzes problems and challenges of implementing HTA and pharmacoeconomics evaluation in China.Four main issues are raised in this field.Result and Conclusion Government departments,medical institutions,pharmaceutical companies and research institutes should cooperate and promote use of pharmacoeconomics evaluation to solve problems.